Transaction · 0001415889-25-005885

Boudreau Philip P

Boudreau Philip P, EVP, reported a transaction classified as grant at ABBOTT LABORATORIES involving 22495.000000 shares for an estimated $0.00. Reported holdings after the transaction were 61461.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code AEVP
ABTABBOTT LABORATORIES
Filing timeFeb 27
Trade dateFeb 25, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

ABT price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ABT since 2025-02-27Filed 554 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001415889-25-005885
Common shares without par value
Transaction date
Feb 25, 2025
Filed Feb 27, 2025, 10:46 PM · 2d delay
Shares
22.4k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
61.4k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Direct Ownership Large Holdings Increase
-12score
Filing-only score

-12

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EXECUTIVE VICE PRESIDENT

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in…

  2. F2

    Balance in the Abbott Laboratories Stock Retirement Trust as of February 25, 2025.

  3. F3

    Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increm…

Original filing · 0001415889-25-005885
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ABT